石药集团1类新药SYH2046获FDA批准开展临床试验

财中社
09 May

5月9日,石药集团(01093)发布公告,宣布其开发的化药1类新药SYH2046片已获得美国食品药品监督管理局(FDA)批准,可以在美国开展临床试验。该产品也已于2025年4月获得中国国家药品监督管理局的批准,允许在中国进行临床试验。SYH2046片是一款具有完全自主知识产权的全新结构first-in-class小分子药物,主要适应症为急性心肌梗死后心力衰竭。临床前研究显示,该产品能够显著改善疾病...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10